Centre for Addiction and Mental Health
camh.caLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
335
Active
72
Phase 3
3
Total enrollment
77,998
Pipeline matrix
Showing 25 of 25 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Haloperidol | — | — | — | — | 2 | ||
| Metformin | — | — | — | — | — | 2 | |
| Nicotine replacement | — | — | — | — | — | 1 | |
| Insulin Lispro | — | — | — | — | — | 1 | |
| Varenicline 1mg BID | — | — | — | — | — | 1 | |
| Nicotine Replacement Therapy Agent | — | — | — | — | — | 1 | |
| Olanzapine | — | — | — | — | — | 1 | |
| paliperidone | — | — | — | — | — | 1 | |
| Clozapine | — | — | — | — | 3 | ||
| risperidone | — | — | — | — | 2 | ||
| Psilocybin | — | — | — | — | 4 | ||
| Psilocybin 25 mg | — | — | — | — | — | 4 | |
| Risperidone 1 MG | — | — | — | — | — | 2 | |
| Oral solution | — | — | — | — | — | 1 | |
| Insulin Lispro 100 UNT/ML | — | — | — | — | 2 | ||
| OLANZapine 2.5 MG | — | — | — | — | — | 1 | |
| Cannabis | — | — | — | — | 4 | ||
| Placebos | — | — | — | — | 2 | ||
| Topiramate | — | — | — | — | 2 | ||
| Intranasal insulin | — | — | — | — | — | 1 | |
| Semaglutide | — | — | — | — | — | 1 | |
| Tobacco | — | — | — | — | — | 1 | |
| Cannabis tobacco | — | — | — | — | — | 1 | |
| Olanzapine 2.5Mg Oral | — | — | — | — | — | 1 | |
| Saline | — | — | — | — | — | 1 |
Next readouts
- 2026-04-30
- 2026-06
- 2026-06-30
- 2026-07
- 2026-07-30
- 2026-08
- 2026-08
- 2026-08-01
- 2026-08-01
- 2026-09-01
Top conditions
- Schizophrenia46
- Major Depressive Disorder35
- Depression28
- Nicotine Dependence18
- Schizoaffective Disorder18
- Psychosis13
- Smoking Cessation12
- Tobacco Use Disorder11
Frequently asked questions about Centre for Addiction and Mental Health
- How many clinical trials does Centre for Addiction and Mental Health have on ClinicalTrials.gov?
- Centre for Addiction and Mental Health is listed as the lead sponsor on 335 clinical trials in ClinicalTrials.gov, 72 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Centre for Addiction and Mental Health's trials are in Phase 3?
- 3 of Centre for Addiction and Mental Health's trials are in Phase 3, spread across 25 active drug programs.
- What therapeutic areas does Centre for Addiction and Mental Health focus on?
- Centre for Addiction and Mental Health's most-studied conditions on ClinicalTrials.gov are Schizophrenia, Major Depressive Disorder, Depression, Nicotine Dependence, Schizoaffective Disorder.
- When are Centre for Addiction and Mental Health's next clinical trial readouts?
- Centre for Addiction and Mental Health has 10 upcoming primary-completion readouts tracked here; the soonest is “Smoking Cessation and Menstrual Cycle Phase”, expected around 2026-04-30.